Chill out. The more important story is that Koos and Lander are failing at bringing any value to the market in any reasonable period, if at all. They’ve had plenty of time to study and test and market to buyers and negotiate a deal.
Further Koos reverts back to attaching his stories to cheesy topical issues like Ebola and now IBS and CBD. C’mon. No one here is buying that garbage. Either he has something that will help cure autoimmune and cancer diseases or he has nothing.
News 
Market Data 
Discover 
